Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials
暂无分享,去创建一个
C. Cooper | T. Berg | G. Dore | H. Wedemeyer | G. Foster | D. Wyles | M. Sulkowski | M. Puoti | Zhenzhen Zhang | E. Villa | Federico Rodríguez-Pérez | E. Dumas | N. N. Alami | J. Grebley | N. Alami | T. Berg